Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of LY3867070 in Healthy Participants
NCT07021547Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of LY3867070, sponsored by Eli Lilly and Company. Started May 2025; status: completed.
02
Drugs
LY3867070
Beyond the preview
Go deeper on NCT07021547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07021547.